Knockdown of METTL3 can significantly increase the sensitivity of pancreatic cancer cells to 5-fluorouracil (5-FU), cisplatin, gemcitabine, and radiotherapy (45). The gene discussed is METTL3; the disease is pancreatic neoplasm.